Autor/es: Alejandro M. Aragona a,*, Nicasio A. Cuneo a, Alejandro H. Soderini a, Elsa B. Alcoba b
a Department of Gynecologic Oncology, Oncology Hospital of Buenos Aires Marie Curie, Autonomous City of Buenos Aires, Argentina
b Department of Pathology, Oncology Hospital of Buenos Aires Marie Curie, Autonomous City of Buenos Aires, Argentina
Resumen: A newhigh-risk groupwas identified based on different cutoff values for tumor size, extra-nodal growth and number of positive lymph nodes. This could be very important in the tailored treatment of a specific group of patients with bulky primary tumors and a poorer prognosis.
